Delivery Order SPE2DB24D2100-SPE2DB25FBAXX
Award Date
11/18/24
Potential Completion Date
11/19/24
Potential Value
$5.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $5,145.40 firm fixed-price delivery order is for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat enlarged prostate. The contract has an ultimate completion date of May 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company and subsidiary of Cencora, Inc. The $1,623.05 firm-fixed-price contract is for the delivery of 1,000 capsules of 0.4 mg Tamsulosin HCl, a medication used to treat an enlarged prostate. The contract has an ultimate completion date of January 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,074.38 firm-fixed-price delivery order is for the supply of 1,000 capsules of Tamsulosin HCl 0.4 mg, a medication used to treat enlarged prostate. The contract has an ultimate completion date of September 9, 2024 and was awarded on September 6, 2024. Amerisourcebergen holds several Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,148.70 firm fixed price delivery order is for the supply of 1,000 capsules of Tamsulosin HCl 0.4 mg, a medication used to treat benign prostatic hyperplasia. The award has an ultimate completion date of November 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,102.10, is a delivery order for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat symptoms of an enlarged prostate. The contract has a firm fixed price and an ultimate completion date of May 20, 2025. This award is not set-aside and represents an open...
This federal contract award, with ID SPE2DB20D3101|SPE2DB23FQWC7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,047.86 firm fixed-price delivery order is for the supply of 100 capsules of Tamsulosin HCl 0.4 mg, a medication used to treat enlarged prostate. The contract has a completion date of December 2, 2022 and does not have a set-aside designation, indicating open competition....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $13,523.94 firm fixed-price delivery order contract is for the supply of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, a medication used to treat an enlarged prostate gland. The contract has an ultimate completion date of March 5, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat an enlarged prostate. The contract is valued at $3,433.57 and has a completion date of June 30, 2025. The contract is not designated as a set-aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a...
This is a $4,564.49 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides for the supply of 500 capsules of Tamsulosin HCl 0.4 mg, a medication used to treat benign prostatic hyperplasia. The award is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,092.88 firm fixed-price delivery order is for the supply of 4,566,719,603 capsules of 0.4 mg Tamsulosin HCl, a medication used to treat benign prostatic hyperplasia. The contract has an ultimate completion date of December 16, 2024 and was awarded on December 13, 2024. AmerisourceBergen holds a significant...